Trial Profile
Effects of 2-week celecoxib treatment on the small intestinal mucosa in Japanese healthy subjects evaluated by capsule endoscopy (A prospective, randomized, double-blind, parallel-group, controlled study compared to the combination of loxoprofen sodium and lansoprazole)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2016
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Lansoprazole; Loxoprofen
- Indications Heartburn; Helicobacter infections; NSAID-induced gastrointestinal damage; Osteoarthritis; Pain; Peptic ulcer; Rheumatoid arthritis
- Focus Adverse reactions
- 05 Mar 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 17 May 2012 New trial record